154 related articles for article (PubMed ID: 21404598)
1. [Review of sentinel surveillance for drug resistance in leprosy conducted by WHO Global Leprosy Programme].
Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):71-7. PubMed ID: 21404598
[No Abstract] [Full Text] [Related]
2. [Our role in sentinel surveillance for drug resistance in leprosy by global leprosy programme].
Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):287-91. PubMed ID: 21941835
[TBL] [Abstract][Full Text] [Related]
3. Report of the WHO workshop on sentinel surveillance for drug resistance in leprosy 20-22 october 2008; Hanoi, Vietnam.
Indian J Lepr; 2009; 81(1):43-54. PubMed ID: 20329363
[No Abstract] [Full Text] [Related]
4. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
[TBL] [Abstract][Full Text] [Related]
5. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam.
Kai M; Nguyen Phuc NH; Nguyen HA; Pham TH; Nguyen KH; Miyamoto Y; Maeda Y; Fukutomi Y; Nakata N; Matsuoka M; Makino M; Nguyen TT
Clin Infect Dis; 2011 Mar; 52(5):e127-32. PubMed ID: 21292655
[TBL] [Abstract][Full Text] [Related]
6. Drug-resistant leprosy: monitoring and current status.
Williams DL; Gillis TP
Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
[No Abstract] [Full Text] [Related]
7. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
Cambau E; Saunderson P; Matsuoka M; Cole ST; Kai M; Suffys P; Rosa PS; Williams D; Gupta UD; Lavania M; Cardona-Castro N; Miyamoto Y; Hagge D; Srikantam A; Hongseng W; Indropo A; Vissa V; Johnson RC; Cauchoix B; Pannikar VK; Cooreman EAWD; Pemmaraju VRR; Gillini L;
Clin Microbiol Infect; 2018 Dec; 24(12):1305-1310. PubMed ID: 29496597
[TBL] [Abstract][Full Text] [Related]
8. [Report of the Ninth meeting of the WHO Technical Advisory Group of Leprosy Control].
Ishii N; Mori S; Nagaoka Y; Suzuki K
Nihon Hansenbyo Gakkai Zasshi; 2009 Feb; 78(1):75-88. PubMed ID: 19227153
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of drug resistance in leprosy: 2009.
Wkly Epidemiol Rec; 2010 Jul; 85(29):281. PubMed ID: 20635520
[No Abstract] [Full Text] [Related]
10. History and characteristics of isolates maintained at the leprosy research center.
Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):247-56. PubMed ID: 20857654
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
12. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
13. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
14. Taking home lessons from the 15th International Leprosy Congress.
Lechat MF
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):562-6. PubMed ID: 10347572
[No Abstract] [Full Text] [Related]
15. [Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries].
Matsuoka M; Suzuki Y; Makino M
Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):257-61. PubMed ID: 20857655
[TBL] [Abstract][Full Text] [Related]
16. Time to define leprosy elimination as zero leprosy transmission?
Smith CS; Aerts A; Kita E; Virmond M
Lancet Infect Dis; 2016 Apr; 16(4):398-9. PubMed ID: 27036335
[No Abstract] [Full Text] [Related]
17. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
18. Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015.
Chauffour A; Lecorche E; Reibel F; Mougari F; Raskine L; Aubry A; Jarlier V; Cambau E;
Clin Microbiol Infect; 2018 Nov; 24(11):1213.e5-1213.e8. PubMed ID: 29906598
[TBL] [Abstract][Full Text] [Related]
19. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
Maeda S
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
[TBL] [Abstract][Full Text] [Related]
20. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
Sapkota BR; Ranjit C; Macdonald M
Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
